All Stories

  1. Structural Insights into Substrate Binding of Brown Spider Venom Class II Phospholipases D
  2. Preparation and Characterization of Monomodal Grapevine Virus A Capsid Protein
  3. Crystallization and preliminary X-ray diffraction studies of anL-amino-acid oxidase fromLachesis mutavenom
  4. Pseudechis guttatus venom proteome: Insights into evolution and toxin clustering
  5. Crystallization and preliminary X-ray diffraction analysis of a novel sphingomyelinase D fromLoxosceles gauchovenom
  6. Recent advances in the understanding of brown spider venoms: From the biology of spiders to the molecular mechanisms of toxins
  7. P-I class metalloproteinase from Bothrops moojeni venom is a post-proline cleaving peptidase with kininogenase activity: Insights into substrate selectivity and kinetic behavior
  8. Elapid Snake Venom Analyses Show the Specificity of the Peptide Composition at the Level of Genera Naja and Notechis
  9. Rapid purification of serine proteinases from Bothrops alternatus and Bothrops moojeni venoms
  10. Structure of the polypeptide crotamine from the Brazilian rattlesnakeCrotalus durissus terrificus
  11. BmooMPα-I (Bothrops moojeni)
  12. Protein C Activators from Snake Venom
  13. Purification, crystallization and preliminary X-ray diffraction analysis of a class P-III metalloproteinase (BmMP-III) from the venom ofBothrops moojeni
  14. Purification, crystallization and preliminary X-ray diffraction analysis of crotamine, a myotoxic polypeptide from the Brazilian snakeCrotalus durissus terrificus
  15. Crystallization and preliminary X-ray diffraction analysis of anL-amino-acid oxidase fromBothrops jararacussuvenom
  16. Crystal structure of a dimeric Ser49 PLA2-like myotoxic component of the Vipera ammodytes meridionalis venomics reveals determinants of myotoxicity and membrane damaging activity
  17. Structure of a novel class II phospholipase D: Catalytic cleft is modified by a disulphide bridge
  18. Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis
  19. Pseudechis australis Venomics: Adaptation for a Defense against Microbial Pathogens and Recruitment of Body Transferrin
  20. Crystallization and preliminary X-ray diffraction analysis of a class II phospholipase D fromLoxosceles intermediavenom
  21. Molecular adaptability of nucleoside diphosphate kinase b from trypanosomatid parasites: stability, oligomerization and structural determinants of nucleotide binding
  22. The structure of a nativel-amino acid oxidase, the major component of the Vipera ammodytes ammodytes venomic, reveals dynamic active site and quaternary structure stabilization by divalent ions
  23. Venom peptide analysis of Vipera ammodytes meridionalis (Viperinae) and Bothrops jararacussu (Crotalinae) demonstrates subfamily-specificity of the peptidome in the family Viperidae
  24. Structural basis for branching‐enzyme activity of glycoside hydrolase family 57: Structure and stability studies of a novel branching enzyme from the hyperthermophilic archaeon Thermococcus Kodakaraensis KOD1
  25. The Venomics of Bothrops alternatus is a Pool of Acidic Proteins with Predominant Hemorrhagic and Coagulopathic Activities
  26. Snake Venomic of Crotalus durissus terrificus—Correlation with Pharmacological Activities
  27. Production, purification, crystallization and preliminary X-ray diffraction studies of the nucleoside diphosphate kinase b fromLeishmania major
  28. SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: Molecular cloning, expression, function and structural analysis
  29. Snake venomics of the Siamese Russell's viper (Daboia russelli siamensis) — Relation to pharmacological activities
  30. Proteome analysis of snake venom toxins: pharmacological insights
  31. Biochemical and Structural Investigations of Bothropstoxin-II, a Myotoxic Asp49 Phospholipase A2 from Bothrops jararacussu Venom
  32. Crystal structure of a novel myotoxic Arg49 phospholipase A2 homolog (zhaoermiatoxin) from Zhaoermia mangshanensis snake venom: Insights into Arg49 coordination and the role of Lys122 in the polarization of the C-terminus
  33. Active and Exo-site Inhibition of Human Factor Xa: Structure of des-Gla Factor Xa Inhibited by NAP5, a Potent Nematode Anticoagulant Protein from Ancylostoma caninum
  34. Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2homologue fromZhaoermia mangshanensisvenom
  35. Interfacial surface charge and free accessibility to the PLA2-active site-like region are essential requirements for the activity of Lys49 PLA2 homologues
  36. Structure of myotoxin II, a catalytically inactive Lys49 phospholipase A2homologue fromAtropoides nummifervenom
  37. Kinetic and mechanistic characterization of the Sphingomyelinases D from Loxosceles intermedia spider venom
  38. Structural insights into the catalytic mechanism of sphingomyelinases D and evolutionary relationship to glycerophosphodiester phosphodiesterases
  39. Correlation of temperature induced conformation change with optimum catalytic activity in the recombinant G/11 xylanase A fromBacillus subtilisstrain 168 (1A1)
  40. Crystallization and preliminary X-ray crystallographic studies of Protac®, a commercial protein C activator isolated from Agkistrodon contortrix contortrix venom
  41. Inhibition of Myotoxic Activity of Bothrops asper Myotoxin II by the Anti-trypanosomal Drug Suramin
  42. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom: toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage
  43. Structural insights for fatty acid binding in a Lys49-phospholipase A2: crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid
  44. Mistletoe lectin I in complex with galactose and lactose reveals distinct sugar-binding properties
  45. Crystallization and high-resolution X-ray diffraction data collection of an Asp49 PLA2 from Bothrops jararacussu venom both in the presence and absence of Ca2+ ions
  46. Crystallization of the Lys49 PLA2 homologue, myotoxin II, from the venom of Atropoides nummifer
  47. Crystallization and preliminary X-ray diffraction analysis of suramin, a highly charged polysulfonated napthylurea, complexed with a myotoxic PLA2 from Bothrops asper venom
  48. Crystal structure of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 in the monomeric and dimeric states: insights into its oligomeric state
  49. Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue‐damaging activities
  50. Purification, characterization and crystallization of Jararacussin-I, a fibrinogen-clotting enzyme isolated from the venom of Bothrops jararacussu
  51. Dissociation of Enzymatic and Pharmacological Properties of Piratoxins-I and -III, Two Myotoxic Phospholipases A2 from Bothrops pirajai Snake Venom
  52. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1
  53. Crystallization and preliminary X-ray diffraction analysis of the catalytic subunit of ADP–glucose pyrophosphorylase from potato tuber
  54. Structural and Functional Characterization of Myotoxin I, a Lys49 Phospholipase A2 Homologue from Bothrops moojeni (Caissaca) Snake Venom
  55. Three-Dimensional Structure of Ribonuclease T1 Complexed with an Isosteric Phosphonate Substrate Analogue of GpU:  Alternate Substrate Binding Modes and Catalysis,
  56. Crystallization, preliminary x‐ray analysis and patterson search of a new aspartic protease isolated from human urine
  57. Crystallization of piratoxin I, a myotoxic Lys49-phospholipase A2 homologue isolated from the venom of Bothrops pirajai
  58. Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin
  59. Crystallization and preliminary diffraction data of two myotoxins isolated from the venoms of Bothrops Asper (terciopelo) and Bothrops Nummifer (jumping viper)
  60. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin
  61. The crystal structure of 1-(Na-trifluoracetylalanyl)-indoline
  62. Crystallization and initial crystallographic results for pepstatin A inhibited bovine cathepsin D
  63. Three-dimensional structure of Gln25-ribonuclease T1 at 1.84-.ANG. resolution: structural variations at the base recognition and catalytic sites